87 related articles for article (PubMed ID: 23347427)
41. Digoxin inhibition of relaxation induced by prostacyclin and vasoactive intestinal polypeptide in small human placental arteries.
Maigaard S; Forman A; Andersson KE
Placenta; 1985; 6(5):435-43. PubMed ID: 3906626
[TBL] [Abstract][Full Text] [Related]
42. Relaxation of ruminal smooth muscle by vasoactive intestinal polypeptide (VIP).
Denac M; Marti J; Scharrer E
Zentralbl Veterinarmed A; 1987 Apr; 34(4):317-20. PubMed ID: 3113113
[No Abstract] [Full Text] [Related]
43. Vasoactive intestinal peptide relaxes isolated strips of human bronchus, pulmonary artery, and lung parenchyma.
Saga T; Said SI
Trans Assoc Am Physicians; 1984; 97():304-10. PubMed ID: 6535346
[TBL] [Abstract][Full Text] [Related]
44. Peptides PHI and VIP: comparison between vascular and nonvascular smooth muscle effect in rabbit uterus.
Bardrum B; Ottesen B; Fahrenkrug J
Am J Physiol; 1986 Jul; 251(1 Pt 1):E48-51. PubMed ID: 3755293
[TBL] [Abstract][Full Text] [Related]
45. A review of the physiology and pharmacology of peripheral (vaginal and clitoral) female genital arousal in the animal model.
Munarriz R; Kim SW; Kim NN; Traish A; Goldstein I
J Urol; 2003 Aug; 170(2 Pt 2):S40-4; discussion S44-5. PubMed ID: 12853772
[TBL] [Abstract][Full Text] [Related]
46. Bradykinin-induced relaxation of renal and pulmonary arteries is dependent upon intact endothelial cells.
Altura BM; Chand N
Br J Pharmacol; 1981 Sep; 74(1):10-11. PubMed ID: 7272593
[TBL] [Abstract][Full Text] [Related]
47. Phosphodiesterase type 1, calcitonin gene-related peptide and vasoactive intestinal polypeptide are involved in the control of human vaginal arterial vessels.
Uckert S; Albrecht K; Kuczyk MA; Hedlund P; Oelke M
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):283-6. PubMed ID: 23490535
[TBL] [Abstract][Full Text] [Related]
48. Vasoactive intestinal polypeptide (VIP) increases vaginal blood flow and inhibits uterine smooth muscle activity in women.
Ottesen B; Gerstenberg T; Ulrichsen H; Manthorpe T; Fahrenkrug J; Wagner G
Eur J Clin Invest; 1983 Aug; 13(4):321-4. PubMed ID: 6413218
[TBL] [Abstract][Full Text] [Related]
49. Effects of VIP and PHM in human intracervical arteries.
Hansen V; Ottesen B; Allen J; Maigaard S; Forman A
Acta Obstet Gynecol Scand; 1988; 67(8):699-701. PubMed ID: 3250182
[TBL] [Abstract][Full Text] [Related]
50. The effects of various peptides on human isolated gut muscle.
Bennett A; Stamford IF; Sanger GJ; Bloom SR
J Pharm Pharmacol; 1992 Dec; 44(12):960-7. PubMed ID: 1361559
[TBL] [Abstract][Full Text] [Related]
51. Myogenic oxidative imbalance interferes with antral motility in obese subjects.
Scirocco A; Pallotta L; Rengo M; Ignazzi A; Carabotti M; Cicenia A; Vona R; Chirletti P; Maselli MA; Donghia R; Coluzzi M; Matarrese P; Silecchia G; Severi C
Dig Liver Dis; 2018 Aug; 50(8):820-827. PubMed ID: 29625905
[TBL] [Abstract][Full Text] [Related]
52. Vasoactive intestinal polypeptide causes relaxation of the pyloric sphincter in the rabbit.
Grisoni E; De Agustin JC; Kalhan SC
J Pediatr Surg; 1993 Sep; 28(9):1117-20. PubMed ID: 8308673
[TBL] [Abstract][Full Text] [Related]
53. Contraction and intracellular calcium-ion elevation of cultured human aortic smooth muscle cells by endothelin-1, vasoactive intestinal contractor (VIC) and the derivatives.
Iwashima A; Kobayashi M; Saida K; Kagamu H; Ohashi S; Arakawa M; Mitsui Y
In Vitro Cell Dev Biol Anim; 1997; 33(10):751-6. PubMed ID: 9466679
[TBL] [Abstract][Full Text] [Related]
54. Non-amidated forms of VIP (glycine-extended VIP and VIP-free acid) have full bioactivity on smooth muscle.
Fahrenkrug J; Ottesen B; Palle C
Regul Pept; 1989 Dec; 26(3):235-9. PubMed ID: 2623188
[TBL] [Abstract][Full Text] [Related]
55. Vasoactive intestinal polypeptide (VIP) provokes vaginal lubrication in normal women.
Ottesen B; Pedersen B; Nielsen J; Dalgaard D; Wagner G; Fahrenkrug J
Peptides; 1987; 8(5):797-800. PubMed ID: 3432128
[TBL] [Abstract][Full Text] [Related]
56. PreproVIP-derived peptides in the human female genital tract: expression and biological function.
Bredkjoer HE; Palle C; Ekblad E; Fahrenkrug J; Ottesen B
Neuropeptides; 1997 Jun; 31(3):209-15. PubMed ID: 9243516
[TBL] [Abstract][Full Text] [Related]
57. In search of mediators of skin vasodilation induced by transcutaneous nerve stimulation: IV. In vitro bioassay of the vasoinhibitory activity of sera from patients suffering from peripheral ischaemia.
Kaada B; Helle KB
Gen Pharmacol; 1984; 15(2):115-22. PubMed ID: 6714638
[TBL] [Abstract][Full Text] [Related]
58. Vasoactive intestinal polypeptide and human vaginal blood flow: comparison between transvaginal and intravenous administration.
Palle C; Bredkjaer HE; Ottesen B; Fahrenkrug J
Clin Exp Pharmacol Physiol; 1990 Jan; 17(1):61-8. PubMed ID: 2350902
[TBL] [Abstract][Full Text] [Related]
59. C-type natriuretic peptide induces inotropic and lusitropic effects in human 3D-engineered cardiac tissue: Implications for the regulation of cardiac function in humans.
Bachmann JC; Kirchhoff JE; Napolitano JE; Sorota S; Gordon WM; Feric N; Aschar-Sobbi R; Lv J; Cao Z; Coppieters K; Borghetti G; Nyberg M
Exp Physiol; 2023 Sep; 108(9):1172-1188. PubMed ID: 37493451
[TBL] [Abstract][Full Text] [Related]
60. Overexpressing miR-122-5p Inhibits the Relaxation of Vaginal Smooth Muscle in Female Sexual Arousal Disorder by Targeting Vasoactive Intestinal Peptide Receptor 1.
Cong S; Gui T; Shi Q; Zhang J; Feng J; Pan L; Ma J; Zhang A
Sex Med; 2021 Aug; 9(4):100390. PubMed ID: 34246178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
